Latest news
Weill Cornell secures $4.2M NIA grant to develop mitochondrial ROS inhibitors for Alzheimer's disease - AllSciAllSci · Wed, 05 Aug 2026 13:25:07 GMTPromatix secures Innovate UK grant to advance cis-bispecific ADC programme - Manufacturing ChemistManufacturing Chemist · Tue, 04 Aug 2026 12:14:55 GMTNiagen Selects Evotec to Advance Preclinical Development of Oral Small-Molecule Candidate - Contract PharmaContract Pharma · Mon, 03 Aug 2026 21:00:00 GMTNiagen Bioscience Selects Global Drug Development Pioneer Evotec to Advance Preclinical Development for NB4168 - Yahoo FinanceYahoo Finance · Mon, 03 Aug 2026 12:32:00 GMT